Remedy Science Secures $20 Million in Latest Series A Funding Round

Remedy Science secured $20 million in its latest Series A, adding another data point to the Healthcare & Life Sciences funding market.

Remedy Science Raises $20 million in Funding

Remedy Science closes Series A funding round led by L Catterton.

Investors Behind the Funding

The round was backed by L Catterton. Funding Intelligence tracks this investor activity alongside sector momentum, co-investor patterns, and recent comparable raises.

Company Profile and Market Context

Remedy Science operates in Healthcare & Life Sciences. Remedy Science's Series A round shows investors are still backing digital health platforms with real scale narratives. At $20M, the deal suggests buyers want category leaders that can turn AI, automation, or workflow leverage into durable enterprise demand.

Strategic Use of Funds

Modernize Dermatologist-Developed Skincare - Yahoo Finance.

Looking Ahead

Remedy Science closes Series A funding round led by L Catterton

Source reference: original announcement/article.